
Class Action Lawsuit Filed Against Pacira BioSciences, Inc. (PCRX): Join Before March 14, 2025 – Levi & Korsinsky Encourages Investors
Breaking News: Pacira BioSciences, Inc. Faces Securities Lawsuit In a recent development, Levi & Korsinsky, LLP, a prominent securities law firm, announced the filing of a class action lawsuit against Pacira BioSciences, Inc. (Pacira or the Company) (NASDAQ: PCRX). The lawsuit alleges securities fraud against the Company and certain of its officers and directors, and…